Delivery Order SPE2DB20D3103-SPE2DB23FN7H3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Glipizide ER 5 mg tablets. The fixed-price delivery order, valued at $1,360.48, has an ultimate completion date of August 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,974.55 firm-fixed-price delivery order is for the supply of 1,000 units of Glipizide ER 10 mg tablets. The award has a completion date of May 10, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,840.94 firm-fixed-price delivery order is for the supply of 4,564,996,919 units of the drug Glipizide ER 5 mg tablets. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $25,226.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,389,606 tablets of the medication Glipizide ER 10 mg, a treatment for diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,564,804,911 tablets of Glipizide ER 10 mg, a medication used to treat type 2 diabetes. The $2,641.54 firm fixed price delivery order was issued under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $6,739.57, is for the delivery of Glipizide ER 10 mg tablets in quantities of 1,000. It is a Firm Fixed Price Delivery Order contract with a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This is a $1,747.49 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLIPIZIDE ER 10 MG TABLET 500S, a generic diabetes medication. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for $1,710.41 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for GLIPIZIDE ER 10 MG TABLET 500S, with a firm fixed price and an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,337.78, is for the delivery of 500 tablets of the medication Glipizide Extended Release 10 milligrams. This is a firm fixed-price delivery order contract, with an ultimate completion date of August 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,396.23, is for the delivery of 4,567,909,357 tablets of Glipizide ER 5 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN7H3Delivery Order
This federal contract award is for the delivery of Glipizide ER 2.5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,920.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/15/23 |